A First-in-Human, Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HM15136(Efpegerglucagon) in Healthy Subjects
Clinical trial NCT04032782 · COMPLETED
Trial details
- NCT number
- NCT04032782
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-02
- Primary completion
- 2019-08-29
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.